A: Ubiquinone is the oxidized state of CoQ10, which requires the body to perform an enzymatic conversion into Ubiquinol before yielding active antioxidant value. Ubiquinol is the pre-reduced, cell-ready active form. Direct ingestion skips the conversion bottleneck, offering superior biological efficiency.

A: Reduced CoQ10 is naturally vulnerable to ambient oxygen. Our technology micro-encapsulates each active molecule inside a dense phospholipid shell. This nanosphere barrier prevents oxygen and ultraviolet light exposure, guaranteeing physical stability throughout manufacturing and retail shelf life.

A: Standard crystalline powders must rely on slow, passive lipid diffusion paths in the intestines. Our liposomal particles mimic natural cellular membranes. This lets the intestinal cells absorb the active matrix via endocytosis (direct cell engulfment), bypassing standard saturation barriers and yielding far higher plasma readings.

A: No. Thanks to the amphiphilic properties of our phospholipid nanospheres, the powder hydrates uniformly in aqueous phases. It sets into a perfectly homogeneous suspension without generating greasy rings, oil surface slicks, or chemical off-notes.

A: Yes. Because the active ubiquinol is sequestered inside the solid lipid matrix, the powder behaves excellently on regular high-speed automated encapsulation lines. It requires no complex nitrogen-blanket installations or specialized atmospheric glove boxes.

A: Absolutely. Our bulk materials undergo rigid ICP-MS verification testing. Every commercial production batch is guaranteed to fall far below the regulatory heavy metal limits defined by both the European Commission and California Prop 6